What Conagen does

Conagen is a privately held synthetic biology and biological manufacturing company founded in 2010 and headquartered in Bedford, Massachusetts. The company engineers microbial strains and runs fermentation-based processes to produce nature-identical ingredients — including sweeteners (BESTEVIA stevia), flavors and fragrances, amino acids, lipids, flavonoids, terpenoids, carotenoids, polysaccharides, human milk oligosaccharides, lactoferrin, postbiotic butyrate (FBA), and debondable hot melt adhesives — for enterprise customers in food and beverage, flavor and fragrance, nutraceuticals, cosmetics, specialty chemicals, and pharmaceuticals.

The technical platform rests on proprietary metabolic pathway engineering and strain development across more than 15 platform organisms, supported by custom laboratory robotics that screens hundreds of thousands of samples daily. Fermentation process development spans microliters in the lab to metric tons at commercial scale, with documented scale-up to 250,000 liters on the Conamax microbial antibody platform, which targets biopharmaceutical manufacturing with productivities above 1 gram per liter per day. Conagen claims 40+ products at commercial scale through its integrated stack of strain engineering, process development, scale-up manufacturing, and analytical chemistry capabilities.

Commercially, Conagen operates a B2B enterprise model with three revenue streams: ingredient supply (one-time product sales of nature-identical compounds), contract manufacturing services (strain development and fermentation scale-up), and technology licensing (e.g., BESTEVIA and Conamax). Pricing is custom and quote-based. Distribution is primarily direct to blue-chip enterprise customers, with selective channel partnerships such as Sweegen, which holds exclusive distribution rights for the BESTEVIA stevia line in food, confection, and beverage. Manufacturing is delivered through exclusive affiliate-company partnerships that provide vertical integration from research through world-scale production. The company is founder-led (CEO and co-founder Oliver Yu) and has raised approximately $30.2M in disclosed funding, headlined by a 2020 strategic investment from Sumitomo Chemical.

Name

Conagen

Legal name

Conagen Incorporated

Website

https://conagen.com

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

51–100 employees

Short description

Conagen is a Bedford, Massachusetts-based synthetic biology company that engineers microbial strains and runs fermentation processes to produce nature-identical ingredients — including stevia sweeteners, flavors, amino acids, HMOs, and antibodies — for enterprise customers in food, nutrition, pharma, and specialty chemicals.

Ownership category

akta.pro rank

Product category

Bio-manufactured Specialty Ingredients

NAICS

Medicinal and Botanical Manufacturing (325411), Nonchocolate Confectionery Manufacturing (311340), Chemical Manufacturing (325), Food Manufacturing (311)

SIC

Medicinal Chemicals & Botanical Products (2833), Sugar & Confectionery Products (2060), Miscellaneous Chemical Products (2890)

akta.pro primary industry

Cultures, Probiotics & Fermentation Ingredients (Starter Cultures, Yeast, Adjuncts) (CRADAOAI)

akta.pro secondary industries

Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Stabilizer & Texturizer Systems/Blends (Custom Hydrocolloid Blends, Application-Specific Systems) (AFAJAMAK), Impurity / Reference Standard Synthesis & Characterization (HLAGAHAG)

Keywords

• Synthetic biology
• Fermentation manufacturing
• Bio-engineered ingredients
• Monoclonal antibody production
• Natural flavor production

Headquarters

HQ city

Bedford

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

1. B2B Product Sales: Conagen manufactures and sells natural ingredients (sweeteners, flavors, fragrances, nutraceuticals, lipids, amino acids, etc.) to food and beverage, cosmetics, pharmaceutical, and specialty chemical companies. Products are sold under partner brands or as ingredients.
2. Manufacturing Services: Provides fermentation scale-up and manufacturing services for partners, taking products from lab scale through commercial production. Vertically integrated manufacturing capabilities are offered as a service.
3. Technology Licensing: Licenses proprietary technologies and processes such as BESTEVIA stevia production methods and Conamax antibody production platform to partners for use in their products.
4. Ingredient Supply: Supplies nature-identical ingredients to manufacturers who use them in consumer products. Products include vanilla flavor, gamma-decalactone, L-ergothioneine, human milk oligosaccharides, and other specialty compounds.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Conagen is a synthetic biology company that develops and manufactures nature-identical ingredients through proprietary strain development, fermentation, and enzymatic bioconversion processes. They produce sweeteners, flavors, fragrances, amino acids, lipids, flavonoids, HMOs, monoclonal antibodies, debondable adhesives, and specialty chemicals for food, beverage, pharmaceutical, cosmetics, and industrial markets. The company is vertically integrated from research and development through commercial-scale manufacturing, operating as a contract development and manufacturing organization (CDMO) alongside its own branded ingredient portfolio.

Product overview

Conagen is a synthetic biology and biological manufacturing company that develops and produces natural ingredients through proprietary strain development, fermentation, and enzymatic bioconversion. The company offers a portfolio of bio-manufactured products including BESTEVIA® stevia sweeteners, the Conamax™ microbial antibody production platform, amino acids (L-ergothioneine), lipids (gamma-decalactone), flavonoids and phenolics (dihydroquercetin), terpenoids and carotenoids, polysaccharides and oligosaccharides, human milk oligosaccharides (HMOs), postbiotic FBA (butyrate), human lactoferrin, and debondable hot melt adhesives. Conagen also provides contract manufacturing services including strain development, fermentation process development, commercial-scale production, analytical chemistry, and laboratory automation. The company operates as a vertically integrated organization from bench to world-scale production, serving the food and beverage, flavor and fragrance, nutrition, pharmaceutical, cosmetics, and specialty chemical industries.

Differentiator

Problem solved

Functional benefit

Brands

• BESTEVIA: A line of commercial stevia products created through enzymatic bio-engineering, offering superior taste profiles and zero calories for food, confection, and beverage industries. Developed in partnership with Sweegen.
• Conamax (CMAX)

Products and services

• BESTEVIA® Stevia Sweeteners A line of natural zero-calorie stevia sweeteners produced through fermentation, offering superior taste profiles with no bitter aftertaste. Sold to food, confection, and beverage manufacturers as natural food sweeteners.
• Conamax™ (CMAX™) Monoclonal Antibody Platform A proprietary microbial antibody production platform that enables rapid, high-quality therapeutic antibody manufacturing with human-like glycosylation at reduced costs compared to traditional mammalian expression systems. Serves pharmaceutical companies seeking affordable biologics manufacturing.
• Amino Acids & Derived Compounds Fermented amino acids including L-ergothioneine produced through proprietary strain development. Used in nutritional products, infant formula, and pharmaceutical applications for antioxidant properties and healthy aging benefits.
• Lipids & Flavor Compounds Bioengineered lipids including gamma-decalactone and flavor compounds (strawberry, peach, coconut, capsaicin) produced through enzymatic bioconversion and fermentation for infant formulas, fortified foods, nutraceuticals, and fragrances.
• Flavonoids and Phenolics Biosynthesized flavonoids and phenolic compounds including dihydroquercetin (DHQ), pyrroloquinoline quinone, catechins, and curcuminoids. Used as antioxidants, preservatives, and functional ingredients in cosmetics, nutraceuticals, and functional beverages.
• Terpenoids and Carotenoids Diverse terpenoid and carotenoid compounds produced through high-yielding fermentation platforms, including natural pigments, functional ingredients, nutritional supplements, food flavorings, fragrances, and colorants.
• Polysaccharides & Oligosaccharides Carbohydrate synthesis products including pharmaceutical compounds (heparin, chondroitin), stevia glycosides, and food ingredients. Used as dietary fibers, thickening agents, emulsifiers, stabilizers, prebiotics, and fat replacers.
• Human Milk Oligosaccharides (HMOs) Scalable, non-GMO HMOs including 2'-fucosyllactose (2'-FL) produced through enzymatic processes for infant nutrition applications, enabling brands to fortify digestive and immune wellness.
• FBA (Postbiotic Butyrate) An odorless butyrate compound developed for digestive and gut health applications in infants and adults. The first odorless source of butyrate, available for licensing for dietary supplements and nutritional products.
• Human Lactoferrin Fermentation-produced human lactoferrin for infant nutrition and iron deficiency applications, offering high quality, sustainable, rapid, and cost-effective production with simplified downstream purification.
• Debondable Hot Melt Adhesives Sustainable, high-performance structural adhesives that are strong yet can be debonded before final finishing operations. A patented solution that outperforms petroleum-based products with sustainable advantages.
• Natural Flavors & Fragrances Natural flavors and fragrances produced through enzymatic conversion and microbial culture, including mint, fruit flavors (peach, strawberry, orange, vanilla, coconut), floral scents (rose, violet), and natural colorants.
• Fermentation Process Development Services Biological process development services for scaling fermentation from microliters to metric tons, with processes developed for 40+ different products at commercial scale. Provided to enterprise partners on a contract basis.
• Commercial-Scale Microbial Fermentation Manufacturing World-scale contract manufacturing capabilities for microbial fermentation products from pilot to commercial production, with facilities capable of scaling up to 250,000 liters.
• Strain Development & Metabolic Pathway Engineering Services Development of novel microbial strains using 14+ different platform organisms and proprietary tools for industrial fermentation of sustainable bio-products. Provided to enterprise partners on a contract basis.

Quantifiable outcome

• 40+ products at commercial scale
• +3 more outcomes

Named customers1 record

Segments7 records

Ideal customer profiles6 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature8 records

Partnerships

One partnership is on record.

• SweegencoreGTM or Marketing PartnerConagen partnered with Sweegen to create the Signature BESTEVIA line of commercial Stevia products. Conagen develops and manufactures the products using their proprietary enzymatic bio-engineering process, while Sweegen distributes and sells the products in the food, confection, and beverage industries. This is a core commercial partnership bringing Conagen's natural sweeteners to market under Sweegen's brand.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Amyris: Amyris is a synthetic biology company that engineered yeast strains to produce fermentation-derived ingredients including flavors, fragrances, and sweeteners. It is the closest historical peer to Conagen in applying strain engineering to ingredient commercialization at scale, though Amyris's restructuring illustrates both the opportunity and execution risk in this model.
• Ginkgo Bioworks: Ginkgo Bioworks operates a synthetic biology platform that programs microbial strains for customers across food, pharma, and industrial markets. Both companies use proprietary strain engineering to produce nature-identical molecules through fermentation, though Ginkgo's cell engineering platform model and Conagen's vertically integrated manufacturing model differ in go-to-market.
• Codexis: Codexis engineers enzymes and microbial strains for pharmaceutical and food ingredient manufacturing. Both companies serve overlapping end markets (pharma APIs, food ingredients) using protein engineering and fermentation, with comparable emphasis on biocatalysis and process scale-up.

Broad incumbents

• Novonesis (formerly Novozymes): Novonesis is a global leader in industrial enzymes and microbial fermentation, serving food, beverage, and specialty chemical markets. While far larger and more diversified than Conagen, the company competes in the same enzyme and fermentation ingredient categories and operates at world-scale.
• dsm-firmenich: dsm-firmenich is a major nutrition, health, and specialty ingredients company with deep positions in flavors, fragrances, and functional food ingredients. The company's broad ingredient portfolio and global manufacturing footprint overlap with several of Conagen's target markets.
• International Flavors & Fragrances (IFF): IFF is a major global supplier of flavors, fragrances, and food ingredients, including products produced via fermentation and biotechnology. Conagen's flavors and fragrances business targets customers who currently purchase from IFF, making it a key incumbent competitor.
• Cargill: Cargill is one of the world's largest food ingredient suppliers, with significant investments in fermentation-based sweeteners, flavors, and specialty ingredients. Conagen competes for ingredient supply contracts with food and beverage customers who currently buy from Cargill.
• Ajinomoto: Ajinomoto is a global leader in fermentation-based amino acid production and a major food and nutraceutical ingredient supplier. Conagen's amino acids product line (including L-ergothioneine) directly competes with Ajinomoto's offerings in nutritional and pharmaceutical markets.
• Chr. Hansen (now part of Novonesis): Chr. Hansen specializes in fermentation-based ingredients including cultures, enzymes, and natural colors for food, beverage, and supplement markets. Its fermentation platform and microbial strain capabilities are directly comparable to Conagen's core technology.

Others

• Sweegen: Sweegen is a sweetener ingredient company that commercializes stevia and other natural sweeteners for food and beverage customers. Sweegen is primarily a customer/distribution partner of Conagen for the BESTEVIA product line rather than a direct competitor, but it illustrates the type of ingredient company in Conagen's commercial orbit.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/conagen
• LinkedInlinkedin.com/company/conagen-inc.

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Conagen